Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Addus HomeCare
DA
DanielGC
Community Contributor
Quality at a Premium. A time to watch, not to buy?
Key Takeaways Consistent revenue growth, strong profitability, and a pristine balance sheet position Addus for sustained disciplined acquisitive growth and improved operational efficiency. The company's business model is resilient and defensive against cyclical downturns, making it a safe haven in times of economic uncertainty.
View narrative
US$154.56
FV
26.1% undervalued
intrinsic discount
14.72%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
2
users have commented on this narrative
51
users have followed this narrative
about 1 month ago
author updated this narrative
Grab Holdings
BL
BlackGoat
Community Contributor
GRAB: The Super-App at the Heart of Southeast Asia’s Digital Boom
Why I Began Following This Company… My interest in Grab begins with the region it calls home. Southeast Asia is entering a transformative decade: young, fast-growing, and increasingly digital.
View narrative
US$8.2
FV
21.3% undervalued
intrinsic discount
21.73%
Revenue growth p.a.
Set Fair Value
27
users have liked this narrative
3
users have commented on this narrative
58
users have followed this narrative
Updated
narrative
Verve Group
ME
MEB
Community Contributor
Verve Group to Surge with 51.61% Revenue Growth
Verve Group faces near-term skepticism following its FY25 Q2 report, which included a downward revision to full-year revenue guidance. But beneath the short-term noise lies a company undergoing a strategic inflection — one that positions it to capture outsized value in the post-cookie, privacy-first advertising economy.
View narrative
€6
FV
61.2% undervalued
intrinsic discount
58.08%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
1
users have commented on this narrative
24
users have followed this narrative
21 days ago
author updated this narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Immunocore Holdings
AN
AnalystLowTarget
Community Contributor
European Price Controls Will Erode Immunotherapy Viability
Key Takeaways Reliance on favorable drug pricing and a single lead product increases vulnerability to future regulatory and market shifts, risking income and growth stability. Escalating competition and regulatory hurdles threaten both technology relevance and clinical pipeline progress, undermining long-term commercial viability.
View narrative
US$24.93
FV
33.4% overvalued
intrinsic discount
4.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
19 days ago
author updated this narrative
Arcus Biosciences
AN
AnalystConsensusTarget
Based on Analyst Price Targets
Phase 3 Trials Will Shape Casdatifan Prospects Despite Regulatory Hurdles
Key Takeaways Arcus Biosciences is focusing on casdatifan's late-stage development, promising significant differentiation and competitive advantage in the RCC market. Strong financial partnerships and a long cash runway ensure sustained R&D investment and potential earnings growth through strategic planning.
View narrative
US$28.36
FV
55.9% undervalued
intrinsic discount
7.68%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
18 days ago
author updated this narrative
IRFC
Indian Railway Finance
AN
AnalystConsensusTarget
Based on Analyst Price Targets
Government Rail And Infrastructure Expansion Will Offset Overvaluation Risks
Key Takeaways Growth and profitability rely on sustained infrastructure expansion, robust loan demand, and favorable funding costs; any slowdown, policy shift, or competition could pressure margins and earnings. Market expectations for stable asset quality, minimal overhead, and tax benefits heighten risks if operational missteps, rising provisions, or earlier tax outflows occur.
View narrative
₹60
FV
114.2% overvalued
intrinsic discount
15.54%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
47
users have followed this narrative
19 days ago
author updated this narrative
Vitru Brasil Empreendimentos Participações e Comércio
AN
AnalystConsensusTarget
Based on Analyst Price Targets
Hybrid Learning Expansion Will Drive Progress Amid Regulatory Challenges
Key Takeaways Scalable hybrid learning and ongoing tech investment position the company to capture flexible education demand and improve student retention and operating leverage. Regulatory agility, network quality, and tax-driven corporate simplification reinforce competitive strength and support future margin and earnings growth.
View narrative
R$12.74
FV
7.2% undervalued
intrinsic discount
3.36%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
19 days ago
author updated this narrative
Flora Growth
AN
AnalystConsensusTarget
Based on Analyst Price Targets
US Cannabis And European Beverage Markets Will Create Opportunities
Key Takeaways Regulatory changes and strategic U.S. expansion could significantly enhance Flora's presence and revenue growth in the cannabis industry. Expansion into the infused beverage market and European operations are expected to drive revenue growth and improve profit margins through innovation and strategic partnerships.
View narrative
US$93
FV
64.0% undervalued
intrinsic discount
8.73%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
18 days ago
author updated this narrative
Libstar Holdings
AN
AnalystConsensusTarget
Based on Analyst Price Targets
Ambient Products And Cape Herb & Spice Integration Will Succeed
Key Takeaways Strategic focus on ambient products and international expansion drives revenue growth and margin improvement through integration, efficiency, and diversification efforts. Simplifying portfolio and investing in capacity-enhancing projects aim to improve earnings stability, return on capital, and operational efficiencies.
View narrative
R3.43
FV
53.3% overvalued
intrinsic discount
4.88%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
19 days ago
author updated this narrative
Clarus
AN
AnalystLowTarget
Community Contributor
Digital Shifts And Pricing Wars Will Compress Margins
Key Takeaways Shifting consumer preferences and adverse weather trends challenge Clarus' core market, risking stagnant sales and reduced demand for its key outdoor brands. Intensifying price competition, regulatory costs, and niche brand dependence threaten margins and long-term earnings, increasing risks of underperformance and weak cash flow.
View narrative
US$3
FV
24.7% overvalued
intrinsic discount
4.23%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
19 days ago
author updated this narrative
Reece
AN
AnalystConsensusTarget
Based on Analyst Price Targets
Network Expansion And Digital Investments Will Unlock Long-Term Demand
Key Takeaways Strategic investments in network, digital, and product innovation position Reece to capture emerging demand and benefit from premium, eco-friendly market trends. Expansion in the U.S. and focus on operational efficiency offer future growth opportunities as market conditions recover, supporting higher margins and recurring revenue.
View narrative
AU$11.82
FV
0.3% undervalued
intrinsic discount
3.08%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
19 days ago
author updated this narrative
Woodside Energy Group
AN
AnalystLowTarget
Community Contributor
Scarborough And Louisiana LNG Projects Will Falter Under Renewables Pressure
Key Takeaways Reliance on LNG and oil leaves Woodside exposed to demand erosion and margin pressure from global decarbonization efforts and cheaper renewable energy alternatives. Stricter regulations, rising funding costs, and increased competition threaten profitability, project execution, and long-term earnings growth.
View narrative
AU$22.76
FV
0.2% overvalued
intrinsic discount
-5.19%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
19 days ago
author updated this narrative